The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin combined with doxorubicin, ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

This trial is looking at a new drug called MK-4280A for Hodgkin lymphoma. This trial is comparing standard treatment with 2 newer combinations of treatment ... When diagnosed at its earliest stage, ...

We thank Yutaka Shimazu for his constructive comments on our HD21 trial.1 In the PET-2 positive cohort, 165 (69%) of 240 patients treated with brentuximab vedotin, etoposide, cyclophosphamide, ...